1-(3-chlorophenyl)piperazine has been researched along with ro 16-0154 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boutros, NN; Cooper, T; D'Souza, DC; Donahue, L; Ebersole, JS; Gil, RB; Krystal, JH; MacDougall, LM; Seibyl, J; Zuzarte, E | 1 |
1 trial(s) available for 1-(3-chlorophenyl)piperazine and ro 16-0154
Article | Year |
---|---|
gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
Topics: Analysis of Variance; Anxiety; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Drug Synergism; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Humans; Male; Models, Neurological; Perceptual Disorders; Piperazines; Psychoses, Substance-Induced; Receptors, GABA-A; Receptors, Serotonin, 5-HT2; Reference Values; Serotonin; Serotonin Receptor Agonists | 2006 |